A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/205 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2469925
This invention relates to use of a carnitine selected from L-carnitine or alkanoyl L-carnitine, preferably acetyl L-carnitine, or of a pharmaceutically acceptable salt thereof for the preparation of a medicament useful for treating depression in a subject, particularly geriatric subjects. The advantage of the invention stands in the efficacy of the carnitine and the lack of important side effects typical of well-known antidepressants.
Cette invention porte sur l'utilisation d'une carnitine sélectionnée parmi L-carnitine ou alkanoyle L-carnitine, de préférence acétyle L-carnitine ou d'un sel acceptable d'un point e vue pharmaceutique de celle-ci dans la préparation d'un médicament utile pour traiter la dépression chez un sujet, notamment les vieillards. L'avantage de cette invention repose sur l'efficacité de la carnitine et l'absence d'effets secondaires importants typiques des antidépresseurs notoirement connus.
Gershon Samuel
Pettegrew Jay W.
Fetherstonhaugh & Co.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
LandOfFree
Carnitine in the treatment of geriatric depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carnitine in the treatment of geriatric depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carnitine in the treatment of geriatric depression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1458026